Immunoprevention of chemical carcinogenesis through early recognition of oncogene mutations

Journal of Immunology

Volumn 194, Issue 6, 2015, Pages 2683-2695

  Nasti, Tahseen H ^a   Rudemiller, Kyle J ^a   Cochran, J Barry ^a   Kim, Hee Kyung ^a,b   Tsuruta, Yuko ^a,b   Fineberg, Naomi S ^c   Athar, Mohammad ^a,b   Elmets, Craig A ^a,b,c   Timares, Laura ^a,b,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DENDRITIC CELL VACCINE; DIMETHYLBENZ[A]ANTHRACENE; DNA VACCINE; EPITOPE; LENTIVIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; POLYCYCLIC AROMATIC HYDROCARBON; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CANCER VACCINE; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CD8+ T LYMPHOCYTE; CELL EXPANSION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GENE MUTATION; IMMUNOSURVEILLANCE; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE H RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PYROSEQUENCING; REGULATORY T LYMPHOCYTE; SKIN CELL; SKIN TUMOR; TUMOR GROWTH; TUMOR REGRESSION; VACCINATION; ADOPTIVE IMMUNOTHERAPY; ANIMAL; C3H MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; INBRED MOUSE STRAIN; METABOLISM; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; PROCEDURES; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR VOLUME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CANCER VACCINES; CARCINOGENS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; DNA MUTATIONAL ANALYSIS; EPITOPES; FEMALE; GENES, RAS; HEK293 CELLS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MICE, INBRED C3H; MICE, INBRED STRAINS; POINT MUTATION; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84924561664     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402125     Document Type: Article

References (48)

1. Rosenberg, S. A., J. C. Yang, and N. P. Restifo. 2004. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10: 909-915.
2. Burnet, F. M. 1970. The concept of immunological surveillance. Prog. Exp. Tumor Res. 13: 1-27.
3. Everall, J. D., and P. M. Dowd. 1978. Influence of environmental factors excluding ultra violet radiation on the incidence of skin cancer. Bull. Cancer 65: 241-247.
4. Hoffmann, D., A. Rivenson, and S. S. Hecht. 1996. The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. Crit. Rev. Toxicol. 26: 199-211.
5. Hecht, S. S. 2002. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 3: 461-469.
6. Vineis, P., M. Alavanja, P. Buffler, E. Fontham, S. Franceschi, Y. T. Gao, P. C. Gupta, A. Hackshaw, E. Matos, J. Samet, et al. 2004. Tobacco and cancer: recent epidemiological evidence. J. Natl. Cancer Inst. 96: 99-106.
7. Shields, P. G. 2000. Epidemiology of tobacco carcinogenesis. Curr. Oncol. Rep. 2: 257-262.
8. Balmain, A., and I. B. Pragnell. 1983. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 303: 72-74.
9. Tang, M. S., S. V. Vulimiri, A. Viaje, J. X. Chen, D. S. Bilolikar, R. J. Morris, R. G. Harvey, T. J. Slaga, and J. DiGiovanni. 2000. Both (+/-)syn-and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess-CAA-to-CTA-mutations at Codon 61 of c-H-ras. Cancer Res. 60: 5688-5695.
10. Scheffzek, K., M. R. Ahmadian, W. Kabsch, L. Wiesmüller, A. Lautwein, F. Schmitz, and A. Wittinghofer. 1997. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277: 333-338.
11. Clark, C. E., S. R. Hingorani, R. Mick, C. Combs, D. A. Tuveson, and R. H. Vonderheide. 2007. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res. 67: 9518-9527.
12. Tran Thang, N. N., M. Derouazi, G. Philippin, S. Arcidiaco, W. Di Berardino-Besson, F. Masson, S. Hoepner, C. Riccadonna, K. Burkhardt, A. Guha, et al. 2010. Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development. Cancer Res. 70: 4829-4839.
13. Schneider, B. L., G. T. Bowden, C. Sutter, J. Schweizer, K. A. Han, and M. F. Kulesz-Martin. 1993. 7,12-Dimethylbenz[a]anthracene-induced mouse keratinocyte malignant transformation independent of Harvey ras activation. J. Invest. Dermatol. 101: 595-599.
14. Kehren, J., C. Desvignes, M. Krasteva, M. T. Ducluzeau, O. Assossou, F. Horand, M. Hahne, D. Kägi, D. Kaiserlian, and J. F. Nicolas. 1999. Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J. Exp. Med. 189: 779-786.
15. Yusuf, N., L. Timares, M. D. Seibert, H. Xu, and C. A. Elmets. 2007. Acquired and innate immunity to polyaromatic hydrocarbons. Toxicol. Appl. Pharmacol. 224: 308-312.
16. Yusuf, N., T. H. Nasti, S. K. Katiyar, M. K. Jacobs, M. D. Seibert, A. C. Ginsburg, L. Timares, H. Xu, and C. A. Elmets. 2008. Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis. Cancer Res. 68: 3924-3930.
17. Xu, S., P. R. Bergstresser, and A. Takashima. 1995. Phenotypic and functional heterogeneity among murine epidermal-derived dendritic cell clones. J. Invest. Dermatol. 105: 831-836.
18. Timares, L., A. Takashima, and S. A. Johnston. 1998. Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Proc. Natl. Acad. Sci. USA 95: 13147-13152.
19. Andersson, H. A., and M. A. Barry. 2004. Maximizing antigen targeting to the proteasome for gene-based vaccines. Mol. Ther. 10: 432-446.
20. Brouwenstijn, N., T. Serwold, and N. Shastri. 2001. MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum. Immunity 15: 95-104.
21. Serwold, T., F. Gonzalez, J. Kim, R. Jacob, and N. Shastri. 2002. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. [see comment] Nature 419: 480-483.
22. Fan, H., Q. Lin, G. R. Morrissey, and P. A. Khavari. 1999. Immunization via hair follicles by topical application of naked DNA to normal skin. Nat. Biotechnol. 17: 870-872.
23. Peachman, K. K., M. Rao, and C. R. Alving. 2003. Immunization with DNA through the skin. Methods 31: 232-242.
24. Belyakov, I. M., S. A. Hammond, J. D. Ahlers, G. M. Glenn, and J. A. Berzofsky. 2004. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J. Clin. Invest. 113: 998-1007.
25. Abel, E. L., J. M. Angel, K. Kiguchi, and J. DiGiovanni. 2009. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protoc. 4: 1350-1362.
26. Nelson, D., C. Bundell, and B. Robinson. 2000. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes. J. Immunol. 165: 6123-6132.
27. Parsons, B. L., P. B. McKinzie, and R. H. Heflich. 2005. Allele-specific competitive blocker-PCR detection of rare base substitution. Methods Mol. Biol. 291: 235-245.
28. Morlan, J., J. Baker, and D. Sinicropi. 2009. Mutation detection by real-time PCR: a simple, robust and highly selective method. PLoS ONE 4: e4584.
29. Chakravarti, D., J. C. Pelling, E. L. Cavalieri, and E. G. Rogan. 1995. Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin papillomas: the role of apurinic sites. Proc. Natl. Acad. Sci. USA 92: 10422-10426.
30. Morris, R. J. 2000. Keratinocyte stem cells: targets for cutaneous carcinogens. J. Clin. Invest. 106: 3-8.
31. Lapouge, G., K. K. Youssef, B. Vokaer, Y. Achouri, C. Michaux, P. A. Sotiropoulou, and C. Blanpain. 2011. Identifying the cellular origin of squamous skin tumors. Proc. Natl. Acad. Sci. USA 108: 7431-7436.
32. Parsons, B. L., and R. H. Heflich. 1998. Detection of a mouse H-ras codon 61 mutation using a modified allele-specific competitive blocker PCR genotypic selection method. Mutagenesis 13: 581-588.
33. Esser, C., I. Bargen, H. Weighardt, T. Haarmann-Stemmann, and J. Krutmann. 2013. Functions of the aryl hydrocarbon receptor in the skin. Semin. Immunopathol. 35: 677-691.
34. Palm, N. W., and R. Medzhitov. 2009. Immunostimulatory activity of haptenated proteins. Proc. Natl. Acad. Sci. USA 106: 4782-4787.
35. Weltzien, H. U., S. F. Martin, and J. F. Nicolas. 2014. T cell responses to contact allergens. EXS 104: 41-49.
36. Denton, A. E., B. E. Russ, P. C. Doherty, S. Rao, and S. J. Turner. 2011. Differentiation-dependent functional and epigenetic landscapes for cytokine genes in virus-specific CD8+ T cells. Proc. Natl. Acad. Sci. USA 108: 15306-15311.
37. Nelson, M. A., B. W. Futscher, T. Kinsella, J. Wymer, and G. T. Bowden. 1992. Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors. Proc. Natl. Acad. Sci. USA 89: 6398-6402.
38. Finch, J. S., H. E. Albino, and G. T. Bowden. 1996. Quantitation of early clonal expansion of two mutant 61st codon c-Ha-ras alleles in DMBA/TPA treated mouse skin by nested PCR/RFLP. Carcinogenesis 17: 2551-2557.
39. Khan, G. A., G. Bhattacharya, P. C. Mailander, J. L. Meza, L. A. Hansen, and D. Chakravarti. 2005. Harvey-ras gene expression and epidermal cell proliferation in dibenzo[a,l]pyrene-treated early preneoplastic SENCAR mouse skin. J. Invest. Dermatol. 125: 567-574.
40. Kim, D. J., K. Kataoka, D. Rao, K. Kiguchi, G. Cotsarelis, and J. Digiovanni. 2009. Targeted disruption of stat3 reveals a major role for follicular stem cells in skin tumor initiation. Cancer Res. 69: 7587-7594.
41. Hennings, H., D. Devor, M. L. Wenk, T. J. Slaga, B. Former, N. H. Colburn, G. T. Bowden, K. Elgjo, and S. H. Yuspa. 1981. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N9-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Cancer Res. 41: 773-779.
42. Wakabayashi, Y., J.-H. Mao, K. Brown, M. Girardi, and A. Balmain. 2007. Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature 445: 761-765.
43. Shankaran, V., H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson, L. J. Old, and R. D. Schreiber. 2001. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410: 1107-1111.
44. Matsushita, H., M. D. Vesely, D. C. Koboldt, C. G. Rickert, R. Uppaluri, V. J. Magrini, C. D. Arthur, J. M. White, Y.-S. Chen, L. K. Shea, et al. 2012. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482: 400-404.
45. Chin, L., A. Tam, J. Pomerantz, M. Wong, J. Holash, N. Bardeesy, Q. Shen, R. O'Hagan, J. Pantginis, H. Zhou, et al. 1999. Essential role for oncogenic Ras in tumour maintenance. Nature 400: 468-472.
46. Siegel, C. T., K. Schreiber, S. C. Meredith, G. B. Beck-Engeser, D. W. Lancki, C. A. Lazarski, Y. X. Fu, D. A. Rowley, and H. Schreiber. 2000. Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein. J. Exp. Med. 191: 1945-1956.
47. Gjertsen, M. K., J. Bjorheim, I. Saeterdal, J. Myklebust, and G. Gaudernack. 1997. Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. Int. J. Cancer 72: 784-790.
48. Gjertsen, M. K., I. Saeterdal, S. Saebøe-Larssen, and G. Gaudernack. 2003. HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes. J. Mol. Med. 81: 43-50.